Sam Herron

ID: 1b83b8f7-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Genentech and Biogen File Joint Stipulation of Dismissal in BPCIA Litigation Regarding Tocilizumab

Big Molecule Watch · October 25, 2023

Update on mRNA Vaccine Patent Litigation

Big Molecule Watch · September 22, 2023

FDA Issues Draft Guidance on Formal Meetings between the FDA and Sponsors or Applicants of BsUFA Products and Classification Categories for Certain Supplements under BsUFA III

Big Molecule Watch · August 16, 2023

Genentech and Tanvex Reach Settlement in Principle in Trastuzumab BPCIA Litigation

Big Molecule Watch · January 20, 2023

Genentech Voluntarily Recalls SUSVIMO (ranibizumab)

Big Molecule Watch · October 27, 2022